When everything else stops working this old med might prolong life a bit. Case study of Megestrol (MA)
“Finally, after disease progression during enzalutamide, we decided to start a new line of hormone therapy. In fact, considering age, PS, and patient’s will, available therapeutic options were running out, but particularly we trusted a disease’s residual sensitivity to androgen receptor-targeted therapies
“Finally, after disease progression during enzalutamide, we decided to start a new line of hormone therapy. In fact, considering age, PS, and patient’s will, available therapeutic options were running out, but particularly we trusted a disease’s residual sensitivity to androgen receptor-targeted therapies